Combo Therapy Cuts Prostate Cancer Death Rates

THURSDAY, Jan. 3 (HealthDay News) -- New research suggests that a common but controversial treatment for prostate cancer reduces long-term death rates without greatly boosting patients' risk of heart problems, as some specialists had feared.

In patients with severe cases of prostate cancer, a combination of testosterone-lowering drugs and radiation therapy appeared to lower the odds of dying of the disease over a 10-year period, from 36 percent to 23 percent.

Healthscout - complete article